Elsevier

Nutrition Research

Volume 20, Issue 3, March 2000, Pages 371-380
Nutrition Research

Human study
Variant alleles of the D2 dopamine receptor gene and obesity

https://doi.org/10.1016/S0271-5317(00)00130-5Get rights and content

Abstract

The mesocorticolimbic dopaminergic reward pathways have a role in the neuromodulation of appetite. There are data supporting a role of allelic variants of the D2 dopamine receptor (DRD2) gene and the number of receptor binding sites in vulnerability to substance abuse and obesity. We recently demonstrated that the A1 and B1 genotypes are in linkage disequilibrium and predictive of smoking status. Previous studies have evaluated the relationship between obesity and A1 but not B1 genotypes. Our objective was to assess the relationships between obesity and DRD2 TaqI A and TaqI B genotypes in healthy individuals. Subjects were 139 Caucasian average weight and 37 obese individuals (body mass index ⩾30) identified as comparison subjects for ongoing case-control studies. Among the obese group, only 41.7% exhibited the A2 genotypes and 58.3% the A1 genotypes compared with 68.8% and 31.2% respectively for the average weight subjects (P=0.002). There was a similar pattern for B2 genotypes (51.4% compared with 78.9% respectively, P=0.003). The risk of obesity associated with the DRD2 A1 genotypes was 3.48 (95% confidence intervals = 1.55, 7.80), compared with 4.55 (1.94, 10.69) for the DRD2 B1 genotypes. Individuals who had the A1 or B1 genotypes had higher BMI than those with the wildtype genotypes (P=0.086 and 0.05 respectively). The prevalence of the A1 genotypes was 2 of 5 (40%) obese individuals who never smoked, 12 of 22 (54.6%) for obese former smokers, and 7 of 9 (77.9%) for obese current smokers. The comparable percentages for the B1 genotypes were 0%, 56.5% and 55.6%. Further emphasis needs to be placed on identifying the genetic basis for obesity in order to develop targeted weight reduction interventions, that may improve potential for success.

References (29)

  • EAH Sims

    Destiny rides again as twins overeat

    N Engl J Med

    (1990)
  • AJ Stunkard et al.

    An adoption study of human obesity

    N Engl J Med

    (1986)
  • DB Allison et al.

    A genetic analysis of relative weight among 4,020 twin pairs, with an emphasis on sex effects

    Health Psychol

    (1994)
  • RR Fabsitz et al.

    Genetic influences on adult weight gain and maximum body mass index in male twins

    Am J Epidemiol

    (1994)
  • Cited by (61)

    • Associations between dopamine D2 receptor availability and BMI depend on age

      2016, NeuroImage
      Citation Excerpt :

      Within the dopamine system, the dopamine D2/3 receptor subtypes (DRD2/3) have been the most widely studied biomarker in relation to obesity. The Taq1A minor (A1) allele of the DRD2/3 gene is associated with lower DRD2/3 density and has been found to exist in higher frequencies in obese subjects (Noble et al., 1994; Blum et al., 1996; Spitz et al., 2000; Barnard et al., 2009). A landmark study in 2001 reported that striatal DRD2/3 availability was reduced in extremely obese subjects relative to control subjects and that striatal DRD2/3 availability correlated negatively with BMI in obese subjects (Wang et al., 2001).

    • Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity

      2015, NeuroImage: Clinical
      Citation Excerpt :

      Most of them are functional magnetic resonance imaging (fMRI) studies. Most genetic fMRI studies investigating food reward have taken into account a common variation (i.e. polymorphism) referred to as TaqIA, of which the A1 allele has been positively associated with BMI in several early genetic studies (Noble et al., 1994; Jenkinson et al., 2000; Spitz et al., 2000; Thomas et al., 2001; Southon et al., 2003). The TaqIA polymorphism is located in the ANKK1 gene, ~10 kb downstream of the DRD2 gene (Neville et al., 2004).

    • The neurobiological underpinnings of obesity and binge eating: A rationale for adopting the food addiction model

      2013, Biological Psychiatry
      Citation Excerpt :

      Much of these findings appear to be modified by a genetic profile affecting dopamine pathways, placing individuals at greater susceptibility for reward system dysfunction. Due to its role in dopamine receptor availability, the A1 allele of the Taq1A gene has been a target for drug and alcohol research over the last 20 years (64) and more recently in hyperphagia leading to obesity (64–66). Presence of the A1 allele can cause a 30% to 40% reduction in striatal D2 receptors (67) and has been implicated in corresponding deficits in glucose metabolism in the OFC, frontal and temporal gyri, insula, hippocampus, and dorsal and ventral striatum (68).

    View all citing articles on Scopus
    View full text